Active	Status	Sponsor type	Region	Phase	Filter
0 Active 3 Inactive 3 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes: « July » « 2025 » M T W T F S S 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1 2 3   - « July » « 2025 » M T W T F S S 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1 2 3   Show only changed items Enrollment:

Advanced Filters

0 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Liproca Depot (hydroxyflutamide) / Lidds, Jiangxi Puheng Pharma
No trials found
BET inhibitor / Lidds
No trials found
NZ-STING / Lidds
No trials found
nanodotax (NZ-DTX) / Lidds
No trials found
nanoimod (NZ-IO-TLR9) / Lidds
No trials found

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Liproca Depot (hydroxyflutamide) / Lidds, Jiangxi Puheng Pharma
No trials found
BET inhibitor / Lidds
No trials found
NZ-STING / Lidds
No trials found
nanodotax (NZ-DTX) / Lidds
No trials found
nanoimod (NZ-IO-TLR9) / Lidds
No trials found